|
⚲
|
| Keyboard |
| Atlas Venture Associates XII LLC | |
|---|---|
| Firm | Atlas Venture Life Science Advisors LLC |
| Address | 400 Technology Square 10th Floor Cambridge, MA 02139 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Atlas Venture Life Science Advisors LLC | |||||
| Atlas Venture Fund XII LP | 021-368325 | Executive Officer | 400.0 M of 400.0 M |
318.2 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2025-08-05 | Disposed to issuer | 4,808,896 | ||
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2025-08-05 | Disposed to issuer | 1,027,978 | ||
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Conversion | 1,027,978 | ||
|
Vigil Neuroscience Inc VIGL
Series A Preferred Stock · derivative
|
2022-01-11 | Conversion | 7,852,374 | $0.00 | |
|
Vigil Neuroscience Inc VIGL
Series B Preferred Stock · derivative
|
2022-01-11 | Conversion | 2,850,789 | $0.00 | |
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Conversion | 2,831,520 | ||
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Buy | 535,000 | $14.00 | 7,490,000 |
|
Jade Biosciences Inc AVTE
Series A Preferred Stock · derivative
|
2021-07-02 | Conversion | 7,976,754 | ||
|
Jade Biosciences Inc AVTE
Common Stock
|
2021-07-02 | Conversion | 2,568,165 | ||
|
Jade Biosciences Inc AVTE
Common Stock
|
2021-07-02 | Buy | 535,714 | $14.00 | 7,499,996 |